ADHD Lisdexamfetamine IND Melatonine Molindone ALS Arimoclomol IND Dementia Aducanumab Depression Bupropion/dextromethorphan Esketamine Spravato, in combination with a SSRI or SNRI, is indicated for adults with treatment-resistant major depressive disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode. Extension of indication to include a new indication for SPRAVATO® (esketamine nasal spray) co-administered with oral antidepressant therapy in adults with a moderate to severe episode of Major Depressive Disorder (MDD), as acute short term treatment, for the rapid reduction of depressive symptoms, which according to clinical judgement constitute a psychiatric emergency. IND Zuranolone Duchenne Golodirsen Epilepsy Brivaracetam IND Cannabidiol IND Cenobamate Fenfluramine Fintepla is indicated for the treatment of seizures associated with Dravet syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older. Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome IND Ganaxolone Lacosamide IND Eye disorders Aflibercept IND Avacincaptad pegol Bevacizumab-vikg Brolucizumab IND Faricimab Lenadogene nolparvovec Netarsudil / latanoprost Perfluorohexyloctane Phentolamine Ranibizumab Wet age-related macular degeneration (AMD). BS Wet age-related macular degeneration (AMD). BS Wet age-related macular degeneration (AMD). BS Wet age-related macular degeneration (AMD). BS Treatment of neovascular age-related macular degeneration (AMD) Reproxalap Sepofarsen Timrepigene emparvovec Headache Atogepant Dihydroergotamine Eptinezumab Erenumab Fremanezumab Galcanezumab Lasmiditan Meloxicam / rizatriptan Rimegepant Multiple sclerosis Dimethyl fumarate Extension of indication to include treatment of relapsing remitting multiple sclerosis (RRMS) in paediatrics patients from 10 years of age and over. IND Volwassenen met 'relapsing remitting' multipele sclerose (RRMS). G Volwassenen met 'relapsing remitting' multipele sclerose (RRMS). G Volwassenen met 'relapsing remitting' multipele sclerose (RRMS). G Diroximel fumarate Natalizumab Ofatumumab Ponesimod Teriflunomide Aubagio is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis. IND Volwassenen met 'relapsing remitting' multipele sclerose (RRMS). G Ublituximab Muscular diseases other AMDC-USR Amifampridine G Bidridistrogene xeboparvovec Sugammadex G Neurological disorders other Cannabidiol gel/intradermaal Eladocagene exuparvovec Inebilizumab Remimazolam Rozanolixizumab Satralizumab Tiratricol Vutrisiran Other psychiatry Dexmedetomidine Pain Bupivacaine extended release IND Fasinumab Lidocaïne Neridronic Acid SDN037 Tanezumab Parkinson's Amantadine Istradefylline Levodopa / carbidopa SMA Onasemnogene abeparvovec Risdiplam Schizophrenia, psychosis, bipolar disorder Lumateperone Sleep disorders Daridorexant JZP-258 Natriumoxybaat controlled release Pitolisant